Patrycja Gralewska-Zając

7PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 13, 2026
Correction: Gralewska-Zając et al. Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer. Int. J. Mol. Sci. 2026, 27, 2630.

|Mar 28, 2026
Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer.

Patrycja Gralewska-Zając, Aleksandra Przybylska, Marek Langner

|Jan 25, 2025
Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines.

Patrycja Gralewska, Łukasz Biegała, Arkadiusz Gajek

|Aug 10, 2024
Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer.

Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak

|Jun 24, 2022
The Influence of PARP, ATR, CHK1 Inhibitors on Premature Mitotic Entry and Genomic Instability in High-Grade Serous BRCA and BRCA Ovarian Cancer Cells.

Patrycja Gralewska, Arkadiusz Gajek, Dorota Rybaczek

|Jun 02, 2021
Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer.

Arkadiusz Gajek, Patrycja Gralewska, Agnieszka Marczak

Pageof 2

Frequent Collaborators

7 joint publications

Aneta Rogalska

6 joint publications

Agnieszka Marczak

4 joint publications

Arkadiusz Gajek

2 joint publications

Agnieszka Śliwińska